Live, oral vaccine for protection against Shigella dysenteriae serotype 1
    3.
    发明授权
    Live, oral vaccine for protection against Shigella dysenteriae serotype 1 有权
    用于保护痢疾志贺氏菌血清型1的活的口服疫苗

    公开(公告)号:US08337831B2

    公开(公告)日:2012-12-25

    申请号:US13285614

    申请日:2011-10-31

    IPC分类号: A01N63/00 C07H21/02 C07H21/04

    摘要: The invention relates to Salmonella typhi Ty21a comprising core-linked Shigella dysenteriae serotype 1 O-specific polysaccharide (O-Ps) and DNA encoding O antigen biosynthesis, said DNA selected from the group consisting of: a) the DNA sequence set out in any one of SEQ ID NOs: 1 and 2 and species homologs thereof; b) DNA encoding Shigella dysenteriae serotype 1 polypeptides encoded by any one of SEQ ID NOs: 1 and 2, and species homologs thereof; and c) DNA encoding a O antigen biosynthesis gene product that hybridizes under moderately stringent conditions to the DNA of (a) or (b); and related sequences, compositions of matter, vaccines, methods of using, and methods of making.

    摘要翻译: 本发明涉及包含核心型痢疾志贺氏菌血清型1型O特异性多糖(O-Ps)和编码O抗原生物合成的DNA的伤寒沙门氏菌Ty21a,所述DNA选自:a)任何一个中列出的DNA序列 的SEQ ID NO:1和2及其物种同系物; b)编码由SEQ ID NO:1和2中任一个编码的痢疾志贺氏菌血清型1多肽的DNA及其同源物; 和c)编码在中等严格条件下与(a)或(b)的DNA杂交的O抗原生物合成基因产物的DNA; 和相关序列,物质组合物,疫苗,使用方法和制备方法。